Portal de Periódicos da CAPES

Avoiding Night‐time Fluid Retention in CAPD Patients

1992; Wiley; Volume: 5; Issue: 2 Linguagem: Inglês

10.1111/j.1525-139x.1992.tb00140.x

1525-139X

Denis Pagé,

Heart Failure Treatment and Management

Seminars in DialysisVolume 5, Issue 2 p. 163-164 Avoiding Night-time Fluid Retention in CAPD Patients Denis E. Pagé, Denis E. Pagé Division of Nephrology University of Ottawa and Ottawa General Hospital Ottawa, Ontario, CanadaSearch for more papers by this author Denis E. Pagé, Denis E. Pagé Division of Nephrology University of Ottawa and Ottawa General Hospital Ottawa, Ontario, CanadaSearch for more papers by this author First published: April 1992 https://doi.org/10.1111/j.1525-139X.1992.tb00140.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Desanto NG, Capodicasa F, Senatore R, Cicchelli T, Cirillo D, Daniano M, Torrella R, Giugliano D, Improta L, Giordano C: Glucose utilization from dialysate in patients on continuous ambulatory peritoneal dialysis. Int J Artif Organs 2: 119–124, 1979. 2 Grodstein GP, Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW: Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int 19: 564–567, 1981. 3 Lindholm B, Bergstrom J, Karlander S-V: Glucose metabolism in patients on CAPD, in Advances in Peritoneal Dialysis, edited by GM Gahl, M Kessel, KD Nolph, Amsterdam , Excerpta, Medica, 1981, p. 413. 4 Boyer J, Gill GN, Epstein F: Hyperglycemia and hyperosmolality complicating peritoneal dialysis. Ann Intern Med 67: 568–572, 1967. 5 Flynn CT, Nanson JA: Intraperitoneal insulin with CAPD–An artificial pancreas. Trans Am Soc Artif Intern Organs 25: 114–116, 1979. 6 Andersson G. Berquist-Poppen M, Bergstrom J, Collsle LG, Hultman E: Glucose absorption from the dialysis fluid during peritoneal dialysis. Scand J Urol Nephrol 5: 77–79, 1971. 7 Nolph KD, Hopkins CA, New D, Antwiler GD, Popovich RP: Differences in solute sieving with osmotic vs. hydrostatic ultrafiltration. Trans Am Soc Artif Intern Organs 22: 618–626, 1976. 8 Blumenkrantz MJ, Gahl GM, Kopple JD, Kamdar AV, Jones MR, Kessel M, Coburn JW: Protein losses during peritoneal dialysis. Kidney Int 19: 593–602, 1981. 9 Diaz-Buxo JA, Walker PJ, Farmer CD, Chandler JT, Holt KL: Continuous cyclic peritoneal dialysis–A preliminary report. Artif Organs 5: 157–161, 1981. 10 Twardowski ZJ: Nightly peritoneal dialysis. Trans Am Soc Artif Intern Organs 36: 8–16, 1990. 11 Sherman RA: Can CAPD run on empty? Arguments for elimination of the overnight dwell. Semin Dial 3: 143–145, 1990. 12 Mactier RA, Khanna R, Twardowski ZJ, Nolph KD. Ultrafiltration failure in continuous ambulatory peritoneal dialysis due to excessive peritoneal cavity lymphatic absorption. Am J Kidney Dis 10: 461–466, 1987. 13 Mactier RA, Khanna R, Twardowski ZJ, Moore H, Nolph KD. Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis. J Clin Invest 80: 1311–1316, 1987. 14 Kagan A, Bar-Khayim Y, Schafer Z, Fainaru M: Kinetics of peritoneal protein loss during CAPD II: Lipoprotein leakage and its impact on plasma lipid levels. Kidney Int 37: 980–990, 1990. 15 Gokal R, King J, Bogle S, Marsh F, Oliver D, Jakubowski C, Hunt L, Baillod R, Ogg C, Ward M, Wilkinson R: Outcome in patients on continuous ambulatory peritoneal dialysis and hemodialysis: 4-year analysis of a prospective multicentre study. Lancet 1: 1105–1109, 1987. 16 Harrison M, Keane W: Host defense mechanisms in chronic ambulatory peritoneal dialysis-associated peritonitis. Semin Dial 2: 117–121, 1989. 17 Cairns HS, Beckett J, Rudge CJ, Thompson FD, Mansell MA: Treatment of resistant CAPD peritonitis by temporary discontinuation of peritoneal dialysis. Clin Nephrol 32: 27–30, 1989. 18 De Jijter CWF, Verbrugh HA, Peter EDJ, Van Der Meulen J, Donher AJM, Verhoef J, Lameire N: Another reason to restrict the use of hypertonic, glucose-based peritoneal dialysis. Its impact on peritoneal macrophage function in vivo. Adv Peritoneal Dial 7: 150–153, 1990. Volume5, Issue2April 1992Pages 163-164 ReferencesRelatedInformation